Patent Yard Sign in
Canadian application, no grantCanada

Cholesterol lowering compounds

CA 2079544 A1 · Owner: Mazur, Adam Weislaw · Inventors: Pikul, Stanislaw; Mazur, Adam Weislaw; Daggy, Bruce P.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

Disclosed are novel saponins containing 5-C-hydroxymethylhexose and a sterol or triterpene. These materials when consumed by, humans and animals, lower the cholesterol level in the blood. These compounds can be administered as pharmaceutical preparation to the diet, or incorporated into food compositions.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 30, 1992. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 30, 2012.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 30, 2014.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 30, 1992
GrantedNo grant recorded
Term endedSeptember 30, 2012
Patent numberCA 2079544 A1
Classification (IPC)C07J71/00 +2 more

Timeline

Timeline From CIPO dates

1993199519971999200120032005200720092011Application filedSep 30, 1992Term endedSep 30, 2012

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.